Chan Mitchell bought RGNX

January 6, 2026 · Form 4 insider transaction

Chan Mitchell bought 73,749 shares of REGENXBIO Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
73,749
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after127,717
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer.

View the original Form 4 on SEC EDGAR